Featured on Forbes: Timeline Shows 3 Paths To COVID-19 Treatment And Prevention

“AbCellera is using proprietary tools and machine learning to rapidly screen through millions of B cells from patients who recovered from COVIDcampaign-pages/bispecifics/-19. B cells are responsible for producing antibodies. The company has announced a partnership with Eli Lilly on this project and aims to bring its hottest antibodies — those that neutralize the virus —to the clinic.”

Read full coverage on Forbes.


Together we can make game-changing discoveries.